Letterbox webp


The British Patient Capital team is based in Sheffield and London. We have a strong culture of collaboration and inclusive team working, and as a closely integrated team, we capitalise on the diversity and variety of experience among our investment professionals.

Our board

Russ Cummings


Russ joined British Patient Capital as an independent Non-executive Director in June 2018 and was appointed Chair on 1 September 2020.

Russ is the former Chief Executive Officer of Touchstone Innovations plc, one of the UK’s leading technology investment companies, championing outstanding science by commercialising innovative research from UK universities. Russ joined as Chief Investment Officer in 2006, then became CEO in 2013 through to the acquisition of Touchstone in 2017 by IP Group plc for £500m.

From 2003 to 2006 he was a Director at the growth equity and venture capital firm Scottish Equity Partners LLP. Prior to this he spent 16 years at the international venture capital and private equity company 3i Group plc, latterly as Director in its UK Technology Group.

Catherine Lewis La Torre


Catherine was appointed CEO of British Patient Capital (BPC) in October 2022, having led the British Business Bank as interim CEO since September 2020. Catherine joined the Bank in 2016 to lead the commercial arm, first as CEO of British Business Investments (BBI) and, from October 2018, as CEO of both BBI and BPC.

Prior to 2016, she was Head of Private Equity for Cardano Risk Management, managing a global portfolio of private capital investments on behalf of UK pension funds. She was previously a Partner and Managing Director of Paris-based European private equity firm, Fondinvest Capital, and before that a founding partner of Nordic Private Equity funds manager, Proventure. Catherine also established a consultancy business advising sovereign wealth funds and institutional investors in Asia, the Middle East and the US on their European private capital strategies.

Catherine is a member of the Rose Review Board.

Hazel Moore, OBE

Non-Executive Director

Hazel joined British Patient Capital as an independent Non-executive Director in June 2019. Hazel is the co-founder and Chair of FirstCapital, an investment bank which provides mergers and acquisitions, private equity and growth capital advice to high-growth technology companies. Until 2023 Hazel was a member of the Future Fifty advisory panel for Tech Nation, the leading programme for scale-up companies in the UK, and she is also an Advisory Board Member of Tech Nordic Advocates, the largest ecosystem for tech companies in the Nordic/Baltic region. She was previously a Governing Board member of Innovate UK, the UK’s national innovation agency, from 2012 to 2018, and served on the Investment Advisory Panel of the North West Fund from 2010–2013.

Hazel was awarded an OBE in the 2017 New Year’s Honours list for services to entrepreneurship and innovation. She won the CBI/Real Business First Women in Finance award in 2016 and the Women in Private Equity Award for Best Corporate Finance Adviser in 2015.

Louis Taylor

CEO of British Business Bank

Louis Taylor is CEO of the British Business Bank. Prior to that, he was Chief Executive of UK Export Finance (UKEF), the UK’s export credit agency, for seven years. He also held roles as a Director General in the Department for International Trade, and a member of its Executive Committee and Management Board.

Before joining UKEF, Louis held a range of senior roles at Standard Chartered Bank, including from 2013 to 2015 as Chief Operating Officer of Group Treasury, based in London. Before that, he spent three years as the bank’s CEO for Vietnam, Cambodia and Laos, based in Ho Chi Minh City. During this time he was also Vice Chairman of the European Chamber of Commerce in Vietnam (Eurocham). He joined Standard Chartered in London in 2004, working in Group Corporate Development, which undertakes the bank’s acquisitions, divestments and other inorganic growth initiatives.

His earlier career included eight years working for JP Morgan in debt capital markets and mergers and acquisitions, and five years in corporate development and strategy with two industrial companies, Cookson Group plc and BTR plc.

Louis is a trustee of the charity Sightsavers, which prevents sight loss and avoidable blindness, and promotes equal rights for the disabled. He is also a former chair of trustees of the charity Music in Prisons, which runs music education projects to help rehabilitate offenders, and a former chair of governors of the Royal Grammar School in Newcastle upon Tyne. He has an MA in Law from the University of Cambridge.

Our team

Ian Connatty

Managing Director, Direct and co-investment

Ian joined in 2018. His previous experience includes working at the British Business Bank and its predecessor, Capital for Enterprise Ltd. He brings with him a wealth of experience in VC fund investing, including close involvement in the deployment of the VC Catalyst which formed the seed portfolio of British Patient Capital.

He previously worked in corporate finance at technology company Infinity SDC and in financial modelling at the Royal Bank of Scotland.

Christine Hockley

Managing Director, Funds

Christine joined in 2018 from the British Business Bank where she spent four years investing in venture capital funds via the VC Catalyst and Enterprise Capital Fund programmes and leading a pilot programme in the lower mid private equity market for British Business Investments, a subsidiary of the Bank. She has investment, corporate finance and commercial experience, having previously worked at the Bank of Scotland, PwC and BOC Industrial Gases.

Mark Andrews

Investment Director, Life Sciences, Funds

Mark joined British Patient Capital in May 2022. His previous experience includes academic medical research as well as many years as a Life Science Venture Capital investor at international investment fund managers. Immediately prior to joining Mark was working in Corporate Advisory working with Life Science clients in the areas of M&A. fund raising, strategy and partnering

Natalie Bangay


Natalie joined in 2018 from the Private Equity team at Aberdeen Standard Investments. Prior to this, she worked in the investment team at SVG Advisers, a subsidiary of SVG Capital. She brings more than a decade of experience in the private equity market, having worked on both primary and secondary investments in buyout and venture capital funds across Europe. Natalie started her career as a management consultant at Corven and Andersen.

Robert Greenwood

Investment Director, Funds

Rob joined in 2018 having worked at the British Business Bank for six years where he was part of the Lending Solutions team and involved with the design and implementation of a number of debt-related programmes before transitioning to the Venture Solutions team in March 2017. Rob previously spent 12 years in corporate and commercial banking with Clydesdale Bank.

He has extensive transaction execution and portfolio management experience.

Tom Haywood

Director, Direct and co-investment

Tom joined British Patient Capital in 2019 from Foresight Group where he focused on the Foresight Williams fund, an early stage deeptech VC fund. Previously, he was an investment manager at EcoMachines Ventures. He co-founded a biotech manufacturing start-up called Puridify that was sold to GE Healthcare and worked in investment banking at Deutsche Bank.

Michael Laycock

Director, Funds

Michael joined British Patient Capital in 2022 from the British Business Bank, where he has spent six years making over £500m of commitments to venture and growth stage equity fund via the VC Catalyst and Enterprise Capital Fund programmes.

Prior to joining the British Business Bank, Michael has worked in various roles across financial services at Bank of New York Mellon, Barclays and Coal Pension Trustees (the management company of the former British Coal pension schemes).

David Phillips

Portfolio Director

David joined British Patient Capital in October 2022. He is an experienced portfolio director having spent nine years at Downing, an early-stage London-based investment manager, and five years at 3i, an international investor focused on mid-market private equity, performing various portfolio management and operations roles.

Sam Baldry

Investment Manager, Funds

Sam joined in January 2019 from Santander’s Credit Risk department where he was involved in managing and updating the monitoring of the credit card portfolio. Prior to that he was a government economist and has experience in financial analysis and modelling.

Dr. Carmine Circelli

Director, Life Sciences, Direct & co-Investment

Carmine joined British Patient Capital in January 2021 from the Northern VCTs, a generalist scaleup investor, where he focused on life sciences investments. Prior to the Northern VCTs, Carmine was an Investment Executive in the technology ventures team at the Development Bank of Wales. He also has university intellectual property commercialisation experience from his time with Cambridge Enterprise. Carmine holds a PhD in Cardiovascular Medicine from the University of Manchester.

Dr. Charlotte Davison

Investment Manager, Life Sciences, Direct and co-Investment

Charlotte joined British Patient Capital in 2021 following a research role with a European corporate venture capital firm.

Alex Faulconbridge

Analyst, Funds

Alex joined British Patient Capital’s funds team from British Business Bank in 2021, where he had been working as a data analyst for the business intelligence team, focused on the Future Fund programme.

Dr. Arnaud Garçon

Senior Investment Manager, Life Sciences, Funds

Arnaud joined British Patient Capital in October 2021 from the University of Manchester Innovation Factory where he led the commercialisation of innovative technologies and the creation of spin-out companies in life sciences. He previously worked in translational research at Renovo and Syngenta.

Nicolo Giovanetti

Investment Analyst, Fund

Nicolo joined British Patient Capital in November 2022. He previously worked for the World Bank in the FCI Markets and Technology Unit where he took care of the compilation and development of a global database on state-owned enterprises in developing countries.

Chloe Hall

Investment Manager, Direct and co-investment

Chloe joined British Patient Capital in September 2021 from Legal & General, a FTSE 100 asset manager, where she was an early-stage venture investor. Her tenure at Legal & General was segmented into health tech investing and a secondment to ADV, a generalist seed-stage fund manager. Prior to this, she was a transactions advisor for growth-stage deep-tech companies.

Jake Hobbs

Investment Manager, Life Sciences, Funds

Jake joined British Patient Capital in December 2020 from BioCity, a UK life sciences incubator and accelerator, where he focused on early stage life sciences investments. Previously, he worked as a lab scientist at Pfizer, AstraZeneca, and Source Bioscience. Jake holds a Masters in Applied Biopharmaceutical Biotechnology and Entrepreneurship from the University of Nottingham, as well as a BSc in Biochemistry from the University of Bath.

Pinky Ghosh

Investment Analyst, Funds

Pinky joined in 2018 from a UK-based manufacturing unit where she worked in finance. Prior to this, she was a Senior Investment Analyst at Zacks Investment Research, a leading American firm, where she focused on investment research and financial write-ups on the US equities market. She started her career in leading financial services groups in India, working in portfolio management services in equities and commodities markets.

Emma Johnson

Senior Investment Manager, Life Sciences, Direct and co-investment

Emma joined British Patient Capital in September 2021 as an Investment Manager in the Direct Investments team, where she focuses on opportunities in the life sciences. Previously, Emma spent three years investing in a broad array of life sciences companies for the Greater Manchester and Cheshire Life Sciences Fund managed by Catapult Ventures. Emma also joined Fund Her North as a founding member with the goal of increasing access to finance for female entrepreneurs in the North of England.

Max Middleton

Senior Investment Manager, Direct and co-investment

Max joined British Patient Capital in September 2021 from Vala Capital where he worked on early-stage investments with a focus on sustainability. Previously, he was an Investment Manager at the Ingenious Group with a mandate to invest in ‘infrastructure-tech’, including clean energy and the built environment. He has over six years’ experience investing in and supporting start-ups.

George Mills

Senior Investment Manager, Direct and co-investment

George joined British Patient Capital in July 2021 from BGF where he worked on early-stage technology investments. Previously, he was an Associate and company founder with Arts Alliance Ventures, and has co-founded three companies.

Joana dos Reis

Investment Manager, Life Sciences, Funds

Joana joined British Patient Capital in December 2021. Previously she was responsible for access to finance at the cluster organization MedCity, including running their life sciences investment network, where she worked closely with early-stage companies and investors, did scientific and commercial due diligence and provided an education in the sector. Joana holds a PhD in Biochemical Engineering from University College London.

Chris Smart

Senior Investment Manager, Funds

Chris joined British Patient Capital in 2018 from the British Business Bank where he worked in Financial Risk supporting the Bank’s various equity programmes. Prior to this he worked in a number of roles at the Royal Bank of Scotland, including Financial Sponsor Coverage providing banking products to UK and European mid-market buyout firms.

Francis Tengenesha

Senior Investment Manager, Funds

Francis Tengenesha joined British Patient Capital in November 2022. He spent the prior six years managing the alternative investments funds portfolio of the West Yorkshire Pension Fund. He began his career in the Investment Office of Coutts Private Bank and worked in fixed income portfolio management at Colchester Global Investors.

Alexandra Woodman

Analyst, Direct and co-investment

Alexandra joined British Patient Capital in July 2021 from Speedinvest, a European seed-stage VC, where she was part of the Marketplace and Consumer investment team. She started her career in corporate finance, working on Consumer and TMT M&A deals.

David Woods

Investment Manager, Funds

David joined British Patient Capital in April 2019 from a specialist deal origination firm where he led the private equity department, sourcing investments for institutional firms and family offices. He has four years of financial services experience.

Richard O'Brien

Investment Manager, Funds

Richard joined the British Business Bank in 2016 and transitioned to British Patient Capital at its formation in 2018. He has led and supported a number of commitments to venture capital funds via the VC Catalyst and Enterprise Capital Fund programmes. Richard previously held roles in the actuarial sector, at a risk arbitrage fund, in foreign currency banking, and at a Fintech start-up, and has investment, analytical and modelling experience.